These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 1448472)

  • 1. Rodent model of nicotine abstinence syndrome.
    Malin DH; Lake JR; Newlin-Maultsby P; Roberts LK; Lanier JG; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1992 Nov; 43(3):779-84. PubMed ID: 1448472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Hebert KM; Conrad DL; Wilson OB
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):180-4. PubMed ID: 7862893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rodent model of cocaine abstinence syndrome.
    Malin DH; Moon WD; Moy ET; Jennings RE; Moy DM; Warner RL; Wilson OB
    Pharmacol Biochem Behav; 2000 Jun; 66(2):323-8. PubMed ID: 10880685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.
    Hildebrand BE; Nomikos GG; Bondjers C; Nisell M; Svensson TH
    Psychopharmacology (Berl); 1997 Feb; 129(4):348-56. PubMed ID: 9085404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible.
    Malin DH; Lake JR; Payne MC; Short PE; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1996 Jan; 53(1):81-5. PubMed ID: 8848464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Wilson OB
    Psychopharmacology (Berl); 1993; 112(2-3):339-42. PubMed ID: 7871039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine abstinence in the mouse.
    Isola R; Vogelsberg V; Wemlinger TA; Neff NH; Hadjiconstantinou M
    Brain Res; 1999 Dec; 850(1-2):189-96. PubMed ID: 10629764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Hydroxytryptophan attenuates somatic signs of nicotine withdrawal.
    Ohmura Y; Jutkiewicz EM; Yoshioka M; Domino EF
    J Pharmacol Sci; 2011; 117(2):121-4. PubMed ID: 22001627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium.
    Malin DH; Lake JR; Schopen CK; Kirk JW; Sailer EE; Lawless BA; Upchurch TP; Shenoi M; Rajan N
    Pharmacol Biochem Behav; 1997 Nov; 58(3):695-9. PubMed ID: 9329061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
    Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine.
    Malin DH; Lake JR; Upchurch TP; Shenoi M; Rajan N; Schweinle WE
    Pharmacol Biochem Behav; 1998 Jul; 60(3):609-13. PubMed ID: 9678643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine abstinence syndrome precipitated by an analog of neuropeptide FF.
    Malin DH; Lake JR; Short PE; Blossman JB; Lawless BA; Schopen CK; Sailer EE; Burgess K; Wilson OB
    Pharmacol Biochem Behav; 1996 Jul; 54(3):581-5. PubMed ID: 8743632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive immunization against nicotine prevents nicotine alleviation of nicotine abstinence syndrome.
    Malin DH; Lake JR; Lin A; Saldaña M; Balch L; Irvin ML; Chandrasekara H; Alvarado CL; Hieda Y; Keyler DE; Pentel PR; Ennifar S; Basham LE; Naso R; Fattom A
    Pharmacol Biochem Behav; 2001 Jan; 68(1):87-92. PubMed ID: 11274712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-DOPA attenuates nicotine withdrawal-induced behaviors in rats.
    Ohmura Y; Jutkiewicz EM; Domino EF
    Pharmacol Biochem Behav; 2011 Jun; 98(4):552-8. PubMed ID: 21354201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of nicotine withdrawal in adult male and female rats.
    Hamilton KR; Berger SS; Perry ME; Grunberg NE
    Pharmacol Biochem Behav; 2009 Mar; 92(1):51-9. PubMed ID: 19000707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal.
    Wing VC; Shoaib M
    Psychopharmacology (Berl); 2007 Dec; 195(3):303-13. PubMed ID: 17690868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive immunization against nicotine attenuates somatic nicotine withdrawal syndrome in the rat.
    Malin DH; Moon WD; Goyarzu P; Magallanes N; Blair MB; Alexander MR; McDavid L; Spurgeon JL; Ennifar S; Fattom A
    Nicotine Tob Res; 2010 Apr; 12(4):438-44. PubMed ID: 20203107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.